In A Few Words essay by Adam Krieger: "Dialysis keeps people alive, but it also consumes them. We cannot dialyze a broken system, and we must not allow that system to dialyze away our vigilance." What We Cannot Dialyze bit.ly/4f6S8ta (FREE)

1/10 Welcome to #TenPostNephJC Can we move beyond slowing CKD → to actually repairing the kidney? Last #NephJC we discussed Rilparencel, a renal autologous cell therapy (REACT) infusion and its effect on eGFR slope.

excited for today’s AI in Kidney health primer @ Mount Sinai ! @asnkidney.bsky.social

Hey #NephSky 2/10/26 at 9 pm EST we'll discuss #Flozinating into the Future & Beyond... SGLT2i in kidney transplant recipients. What's the latest evidence of risk/benefit? Do #Flozins act mechanistically the same in de-innervated kidneys? Come chat. www.nephjc.com/news/inifinti-flozins-transplant

Here is the VA for the INFINITI study of SGLT2i in transplant patients by @glomerican.bsky.social #NephSky #Flozins #Flozination www.nephjc.com/news/2026/2/8/infiniti-the-visual-abstract

Up next on #NephJC we will be unpacking SGLT2i in transplant recipients👇 journals.lww.com/cja...#NephJC

Oh, the weather outside is frightful 🥶🥶 But #NephJC is so delightful, and since you've no place to go #NephSky... Come discuss POTCAST: potassium goals and cardiac arrhythmias 1/27/26 at 9pm EST on #Bluesky Summary by @shelliefravel.bsky.social @salinesolut.bsky.social www.nephjc.com/news/potcast

⏰2 hours until #NephJC chat Join us today to learn more about the recently released VALIANT study, which investigates the use of Pegcetacoplan in C3 glomerulonephropathy and immune complex mediated glomerulonephritis

Wilst thou join us here, where the Sky is Blue? #NephJC On 1/13/26 at 9pm EST 'tis true We shall converse of the great knight's quest, a VALIANT effort from Sir Pegcetacoplan vs complement! ⚔️ www.nephjc.com/news/valiant-c3g

Tis the season for christmas kidney cookies! Happy Holidays

1/10 Last #NephJC we discussed dialysis frequency in AKI-D #TenPostNephJC We sought to answer an age-old question: Is less is really more? Or less is just simply what it is….less? pubmed.ncbi.nlm.nih.gov/41201895/

Join us for the last #NephJC of 2025, 12/16/25 at 9pm EST!🥳 How soon should we withhold dialysis in AKI? We're discussing the LIBERATE-D trial #NephSky This one might just change your mind 🧠🧠 Blog by @msocomd.bsky.social and @sejalplakhani.bsky.social www.nephjc.com/news/liberated-aki

1/10 Welcome to #TenPostNephJC Last #NephJC we discussed the PISCES study 🐟 on the role of fish oil on cardiovascular events in hemodialysis patients. This study was presented at Kidney Week with simultaneous publication, and was as unexpected as a shark attack🦈.

Maybe the most shocking study from #KidneyWk. 🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊? www.nephjc.com/news/pisces-fishoil

Holy Mackerel! 🐟 🦜Ahoy matey! Could fish oil unlock the mysteries of increased CV mortality in ESRD? 🏴‍☠️ #NephJC Join us for a lively trawling trip 12/2/25 🛥️at 9pm EST Check out the PISCES VA by @brianrifkin.bsky.social www.nephjc.com/news/piscesva

Tonite 11/18/25 on #Bluesky 9pm EST We are discussing ORIGIN3 and atacicept in IgAN. APRIL, BAFF and B-cells, Oh My! (🦁🐯🐻) It's going to be Wicked good. 🧙‍♀️ #NephJC Summary by @notjustdialysis.bsky.social www.nephjc.com/news/atacicept-origin3-gtfb36

🚨 New study alert: The American Heart Association’s latest “Cardiovascular-Kidney-Metabolic Syndrome” (CKM) metrics reveal major implications for life expectancy in U.S. adults. Dive into the full life-table analysis 👉 https://ow.ly/MtOT50XkE9P #CardioSky #MedSky

The 2025 @kdigo.org IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over #Nephsky #Medsky ✍️Summary by @thekidneywhisperer.bsky.social and @glomerican.bsky.social www.nephjc.com/news/igan-kd...

Hap-Pee Halloween Friends !! #kidneyjokes #kidneypuns #halloween2025

⏩ Next #NephJC is on IgA nephropathy @kdigo.org guideline 🎨 Nice visual summary by @roxnonna23.bsky.social www.nephjc.com/news/2025/10...

1/10 Last #NephJC we tried to answer the question whether protein supplementation increases health related QoL 🥩💊#TenPostNephJC . Read the article 👇 pubmed.ncbi.nlm.nih....#NephJC

Decision support for PICC Line placement in patients with CKD ca. 2023 #Nephpearls #VascularAccessPearls #NephSky #VisualGraphic by @brianrifkin.bsky.social 👉🏼 pubmed.ncbi.nlm.nih.gov/34218708/

Chimerism might just be the 🔑 to immune tolerance and ending the need for immunosuppression 🚫💊after transplantation 🫘. Join the discussion 9/30/25 at 9 pm EST on Bluesky #NephSky #MedSky #NephJC www.nephjc.com/news/chimera-tolerance-njqe334

It's that time of year again 🍂🍂🍂 The #NephJC Fall pledge drive. Plese give if you are able to support our decades long mission of #FOAMed for all. #NephSky #MedSky www.nephjc.com/news/2025/9/22/nephjc-fall-pledge-drive

#GlomConHawaii 2025 🌴🌊 session: EMBARK Awareness - Closing the Gaps: Unmet Needs and Rising Opportunities for Community Education and Engagement Register here 👉 glomconhawaii.org #GlomConHawaii2025 #GlomConHawaii #GlomCon

❤️Check out the VA for the discussion on the AHA/ACC Hypertension Guidelines 9/16/25 at 9pm EST by @sejalplakhani.bsky.social #NephJC #NephSky #MedSky www.nephjc.com/news/2025/9/ahaacc-htnguide

Agree with this algorithm from evidence.nejm.org/doi/full/10.... ($$$ or sub reqd) Flozinate and Glipinate Metformin only if these are not appropriate or possible All else comes later

Join us #NephJC #NephSky

Check out the ACHIEVE visual abstract by @nephromommy-akshu.bsky.social www.nephjc.com/news/2025/8/...

T0b Expert opinion—not RCTs—has dominated guidelines on phosphorus control in ESRD for decades. Why? Because phosphate feels like a villain... but is it really? 🦹‍♂️ I can feel it in my bones. #NephJC

Check the insightful #NephJC summary by Akshaya Jayachandran ‪@nephromommy-akshu.bsky.social, Natalia Nombera @roxnonna23.bsky.social, Janany Sabescumar @glomerican.bsky.social www.nephjc.com/news/...#NephJC

On 7/22/25 at 9pm EST only on Bluesky! #NephSky #MedSky join us for a lively discussion. We're debating eGFRdiff (the gap that is sometimes present between the eGFR of cystatin C and creatinine). What does it mean, what causes it and what you should do about it. #NephJC www.nephjc.com/news/egfrdiff

As always the @nephjc.bsky.social summer book turns out to be a great and fascinating read. Highly recommended.

🎨Check out the beautiful #visualabstract by #NephJC intern @shelliefravel.bsky.social ⏰Chat happening on July 8, 9 pm EST www.nephjc.com/news/2025/7/...

1/10 Last #NephJC we discussed tacrolimus (TAC) versus mycophenolate mofetil (MMF) for the treatment of pediatric nephrotic syndrome. A first👶to👶immunosuppression study for SSNS in kids #TenPostNephJC . Read the articles 👇 pmc.ncbi.nlm.nih.gov/articles/PMC...

The class of 2025, #NephJC interns www.nephjc.com/news/2025/6/...

Another year another group of fellows leave the nest! Congratulations Annuj and Mumin!

Major Trials in the use of ASIs targeting difficult-to-control hypertension #NephJC

NephJC Internship 2025 Kick-Off! Let's do this!! @nephjc.bsky.social

First collaborative Nephrology/Endocrinology Shark Tank, so proud of our fellows and thanks to our panelist of expert judges!

Women in Medicine Book Club event and the lovely author Dr. Jessi Gold #HowDoYouFeel

Prevent kidney failure to reduce carbon emissions ♻️ 🍃 🏭 Our new analysis of CREDENCE assessing environmental impacts from ⬇️ hospitalisations & dialysis 🏥 with SGLT2i SGLT2i ⬇️ greenhouse gas emissions from inpatient bed days & dialysis by 20% (39 kg CO2e per yr) www.thelancet.com/journals/lan...